Cargando…

Evaluation of the safety, immunogenicity and pharmacokinetics of equine anti-SARS–CoV F(ab′)(2) in macaque()

To warrant potential clinical testing, the equine anti-SARS–CoV F(ab′)(2) requires evaluation in as many animal models as possible and a safety test in a primate model. In this study, we evaluated the pharmacokinetics, tolerance and immunity of this kind of antibody in macaques and rats. Results sho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yunsheng, Jia, Zhengcai, Zhou, Liyun, Wang, Li, Li, Jintao, Liang, Yunfei, Zhao, TingTing, Ni, Bing, Wu, Yuzhang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2007
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106090/ https://www.ncbi.nlm.nih.gov/pubmed/17996696 http://dx.doi.org/10.1016/j.intimp.2007.09.011

Ejemplares similares

Inhibition of infection caused by severe acute respiratory syndrome-associated coronavirus by equine neutralizing antibody in aged mice()
por: Zhou, Lili, et al.
Publicado: (2007)

Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques
por: Rosenberg, Yvonne, et al.
Publicado: (2015)

Equine Immunoglobulin and Equine Neutralizing F(ab′)(2) Protect Mice from West Nile Virus Infection
por: Cui, Jiannan, et al.
Publicado: (2016)

2773. Safety and Immunogenicity Study of Eastern Equine Encephalitis Vaccine
por: Maryam, Keshtkar-Jahromi, et al.
Publicado: (2019)

The Western Equine Encephalitis Lyophilized, Inactivated Vaccine: An Update on Safety and Immunogenicity
por: Keshtkar-Jahromi, Maryam, et al.
Publicado: (2020)

Equine immunoglobulin F(ab')(2) fragments protect cats against feline calicivirus infection
por: Cui, Zhanding, et al.
Publicado: (2019)

Prophylactic Efficacy of Equine Immunoglobulin F(ab′)(2) Fragments Against Feline Parvovirus
por: Liu, Jinfeng, et al.
Publicado: (2021)

Assessment of the effects of immunogenicity on the pharmacokinetics, efficacy and safety of tildrakizumab
por: Kimball, A.B., et al.
Publicado: (2019)

Introduction of the YTE mutation into the non-immunogenic HIV bnAb PGT121 induces anti-drug antibodies in macaques
por: Rosenberg, Yvonne J., et al.
Publicado: (2019)

Preparation and development of equine hyperimmune globulin F(ab′)(2) against severe acute respiratory syndrome coronavirus
por: LU, Jai‐hai, et al.
Publicado: (2005)

Therapeutic efficacy of equine botulism antitoxin in Rhesus macaques
por: Kodihalli, Shantha, et al.
Publicado: (2017)

Preexisting Antibodies to an F(ab′)(2) Antibody Therapeutic and Novel Method for Immunogenicity Assessment
por: Ruppel, Jane, et al.
Publicado: (2016)

Testosterone correlates with Venezuelan equine encephalitis virus infection in macaques
por: Muehlenbein, Michael P, et al.
Publicado: (2006)

Non-clinical safety assessment and in vivo biodistribution of CoviFab, an RBD-specific F(ab′)2 fragment derived from equine polyclonal antibodies
por: Salinas, Facundo, et al.
Publicado: (2022)

PEGylation Prolongs the Half-Life of Equine Anti-SARS-CoV-2 Specific F(ab’)(2)
por: Xu, Mengyuan, et al.
Publicado: (2023)

Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity
por: Schnabel, Christiane L., et al.
Publicado: (2018)

Safety and Immunogenicity of a 4-Component Toxoid-Based Staphylococcus aureus Vaccine in Rhesus Macaques
por: Venkatasubramaniam, Arundhathi, et al.
Publicado: (2021)

Multiple mechanisms mediate enhanced immunity generated by mAb-inactivated F. tularensis immunogen
por: Iglesias, Bibiana V., et al.
Publicado: (2012)

Safety, Pharmacokinetics, and Immunogenicity of Obiltoxaximab After Intramuscular Administration to Healthy Humans
por: Nagy, Christa F., et al.
Publicado: (2017)

Anti-SARS-CoV-2 equine F (Ab′)(2) immunoglobulin as a possible therapy for COVID-19
por: Botosso, Viviane Fongaro, et al.
Publicado: (2022)

Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')(2 )in mice
por: Lu, Jiahai, et al.
Publicado: (2006)

Safety and effectiveness of RBD-specific polyclonal equine F(ab´)(2) fragments for the treatment of hospitalized patients with severe Covid-19 disease: A retrospective cohort study
por: Farizano Salazar, Diego H., et al.
Publicado: (2022)

Protection from infection with influenza A H7N9 virus in a mouse model by equine neutralizing F(ab′)(2)
por: Zhao, Zhongpeng, et al.
Publicado: (2014)

Pharmacokinetics and Immunological Effects of Romidepsin in Rhesus Macaques
por: Kleinman, Adam J., et al.
Publicado: (2020)

AB077. Relationship of TPO-Ab and TSH with in vitro fertilization and embryo transfer
por: Wang, Liyun
Publicado: (2015)

Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of Pelmeg(®), a pegfilgrastim biosimilar in healthy subjects
por: Roth, Karsten, et al.
Publicado: (2019)

Microdialysis in awake macaque monkeys for central nervous system pharmacokinetics
por: Thiollier, Thibaud, et al.
Publicado: (2018)

First-in-human study to assess the safety, tolerability, pharmacokinetics and immunogenicity of DS002, an anti-nerve growth factor monoclonal antibody
por: Ma, Tingting, et al.
Publicado: (2022)

Blood genomic profiles of exposures to Venezuelan equine encephalitis in Cynomolgus macaques (Macaca fascicularis)
por: Hammamieh, Rasha, et al.
Publicado: (2007)

Physiological and immunological changes in the brain associated with lethal eastern equine encephalitis virus in macaques
por: Albe, Joseph R., et al.
Publicado: (2021)

Equine immunoglobulin fragment F(ab’)(2) displays high neutralizing capability against multiple SARS-CoV-2 variants
por: Gupta, Divya, et al.
Publicado: (2022)

Impact of intravenous infusion time on AAV8 vector pharmacokinetics, safety, and liver transduction in cynomolgus macaques
por: Greig, Jenny A, et al.
Publicado: (2016)

Population pharmacokinetics, exposure-safety, and immunogenicity of atezolizumab in pediatric and young adult patients with cancer
por: Shemesh, Colby S., et al.
Publicado: (2019)

Clinical Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anifrolumab
por: Tang, Weifeng, et al.
Publicado: (2023)

Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of CMAB807, a New Denosumab Biosimilar, in Healthy Chinese Subjects
por: Chen, Hanjing, et al.
Publicado: (2022)

Evaluation of the Immunogenicity of Mycobacterium bovis BCG Delivered by Aerosol to the Lungs of Macaques
por: White, A. D., et al.
Publicado: (2015)

A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques
por: Lee, Sujin, et al.
Publicado: (2016)

Pharmacokinetic analysis of topical tobramycin in equine tears by automated immunoassay
por: Czerwinski, Sarah L, et al.
Publicado: (2012)

Protective Efficacy of Centralized and Polyvalent Envelope Immunogens in an Attenuated Equine Lentivirus Vaccine
por: Craigo, Jodi K., et al.
Publicado: (2015)

Predicting the F(ab)-mediated effect of monoclonal antibodies in vivo by combining cell-level kinetic and pharmacokinetic modelling
por: Krippendorff, Ben-Fillippo, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_nag2r8mbq41bu88uajcr4rk7pc